Prosztatarák: vizsgálatok itt: Lettország

1 trial · From ClinicalTrials.gov, checked 2026. november 12.. Ask the study team whether a trial fits you.

• 3. fázisTaking people
  A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

  Where

  Liepaja, Riga

  Életkor

  18 év and over

  People

  1314 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06136650 · EU 2023-504957-11-00